A new weight-loss drug dubbed the 'triple G' could be stronger than Ozempic, Wegovy, and Mounjaro — and as powerful as bariatric surgery

The new weight loss drug, in development by Eli Lilly, could be as powerful as bariatric surgery patients with obesity lost 24% of their body weight.

Related Keywords

San Diego ,California ,United States ,Dublin ,Ireland ,American ,Julio Rosenstock ,Eli Lilly ,Ania Jastreboff ,Carel Le Roux ,Drug Administration ,University College Dublin ,American Diabetes Association ,Yale Obesity Research Center ,University Of Texas Southwestern Medical Center ,New England Journal ,Texas Southwestern Medical Center ,Injectable Drug ,Weight Loss ,Clinical Trials ,Bariatric Surgery ,Type 2 Diabetes ,Ejm ,Investigational Drug ,